FEATURED ARTICLE

Head-to-Head Comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study. Wenjia Zhu et al. See page 897.

Targeting glucose uptake–associated genes: ¹⁸F-FDG PET and low-PSMA tumors in prostate cancer. Martin K. Bakht et al. See page 904.

Leading in crisis: looking at the COVID-19 challenges and strategies in a large U.S. health enterprise. Johnese Spisso and Johannes Czernin. See page 777.